Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield

2 months ago

NEWTOWN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”) today announced its updated…

I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform

2 months ago

New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwideStrategy centers…

Aeroflow Health and UnitedHealthcare Partner to Deliver Virtual Nutrition Services Nationwide

2 months ago

The partnership enables UnitedHealthcare to integrate telehealth nutrition services across Commercial and Medicare plans to enhance patient wellnessASHEVILLE, N.C., Oct.…

PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer

2 months ago

Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to…

Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin

2 months ago

HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…

PolarityBio Announces Acceptance of Category III CPT® Code Application for Autologous Heterogeneous Skin Construct Graft by AMA CPT® Editorial Panel

2 months ago

Secured Category III CPT Codes Pave the Way for Broader Access to Regenerative Skin ConstructSALT LAKE CITY, Oct. 29, 2025…

ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology

2 months ago

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early…

PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025

2 months ago

PETACH TIKVA, Israel, Oct. 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company…

Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics

2 months ago

Kennewick, WA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced enhanced cooperation with Exubrion Therapeutics to…

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

2 months ago

SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…